We are live on ! Find out more
PAM

Paradigm Asset Management Portfolio holdings

AUM $426M
1-Year Est. Return 18.16%
This Fund
S&P 500
This Quarter Est. Return
+4.22%
1 Year Est. Return
+18.16%
3 Year Est. Return
+51.62%
5 Year Est. Return
+67.65%
10 Year Est. Return
+240.73%
AUM
$386M
AUM Growth
-$109M
Cap. Flow
-$127M
Cap. Flow %
-32.8%
Top 10 Hldgs %
9.92%
Holding
586
New
3
Increased
10
Reduced
171
Closed
172

Top Sells

Rank Stock Value
1
MET icon
MetLife
MET
+$1.93M
2
AAPL icon
Apple
AAPL
+$1.58M
3
EOG icon
EOG Resources
EOG
+$1.35M
4
VLO icon
Valero Energy
VLO
+$1.33M
5
EXC icon
Exelon
EXC
+$1.29M

Sector Composition

Rank Sector Weight
1 Financials 19.58%
2 Energy 9.66%
3 Healthcare 8.69%
4 Industrials 7.3%
5 Technology 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYKE
426
DELISTED
SYKES Enterprises Inc
SYKE
-2,800
Closed -$93.9K
PRAH
427
DELISTED
PRA Health Sciences, Inc.
PRAH
-5,800
Closed -$435K
CTB
428
DELISTED
Cooper Tire & Rubber Co.
CTB
-8,300
Closed -$300K
FPRX
429
DELISTED
Five Prime Therapeutics, Inc.
FPRX
-8,200
Closed -$247K
GPOR
430
DELISTED
Gulfport Energy Corp.
GPOR
-4,200
Closed -$62K
INWK
431
DELISTED
InnerWorkings, Inc.
INWK
-9,500
Closed -$110K
CCMP
432
DELISTED
CMC Materials, Inc. Common Stock
CCMP
-5,000
Closed -$369K
LOGM
433
DELISTED
LogMein, Inc.
LOGM
-600
Closed -$62.7K
PTLA
434
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-11,800
Closed -$663K
PGNX
435
DELISTED
Progenics Pharmaceuticals Inc
PGNX
-4,500
Closed -$30.6K
STML
436
DELISTED
Stemline Therapeutics, Inc.
STML
-7,900
Closed -$72.7K
DPLO
437
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
-5,300
Closed -$78.4K
IPHS
438
DELISTED
Innophos Holdings, Inc.
IPHS
-1,900
Closed -$83.3K
WCG
439
DELISTED
Wellcare Health Plans, Inc.
WCG
-2,400
Closed -$431K
MDCO
440
DELISTED
Medicines Co
MDCO
-8,900
Closed -$338K
GWR
441
DELISTED
Genesee & Wyoming Inc.
GWR
-4,700
Closed -$321K
CRR
442
DELISTED
Carbo Ceramics Inc.
CRR
-5,200
Closed -$35.6K
ONCE
443
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
-6,500
Closed -$388K
CBM
444
DELISTED
Cambrex Corporation
CBM
-7,200
Closed -$430K
MDSO
445
DELISTED
Medidata Solutions, Inc.
MDSO
-1,300
Closed -$102K
WAGE
446
DELISTED
WageWorks, Inc.
WAGE
-5,900
Closed -$396K
ARRY
447
DELISTED
Array Biopharma Inc
ARRY
-31,700
Closed -$265K
QTNA
448
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
-2,800
Closed -$53.2K
ULTI
449
DELISTED
Ultimate Software Group Inc
ULTI
-400
Closed -$84K
IMPV
450
DELISTED
Imperva, Inc.
IMPV
-1,300
Closed -$62.2K

Similar funds

Paradigm Asset Management's Q3 2017 Portfolio in Review

As of Q3 2017, Paradigm Asset Management held 586 positions worth $386M, down 22% from $495M the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Paradigm Asset Management withdrew a net $127M in Q3 2017, closing 172 positions and reducing 171 holdings. Its most notable exit was Supernus Pharmaceuticals, an estimated $668K position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Paradigm Asset Management opened a new position in Brighthouse Financial worth $464K.

  • Paradigm Asset Management's largest Q3 2017 buy was Brighthouse Financial: 7,636 shares worth $464K.
  • Paradigm Asset Management added most to Baidu in Q3 2017, an estimated $218K increase.
  • Paradigm Asset Management's biggest Q3 2017 reduction was MetLife, cutting an estimated $1.93M.
  • Paradigm Asset Management fully exited Supernus Pharmaceuticals in Q3 2017, selling an estimated $668K.
  • Paradigm Asset Management's ten largest holdings make up 9.9% of its $386M portfolio in Q3 2017.
  • Paradigm Asset Management opened 3 new positions and closed 172 in Q3 2017.
  • Paradigm Asset Management's portfolio value fell 22% quarter-over-quarter to $386M.

Based on Paradigm Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.